Related references
Note: Only part of the references are listed.Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen J. Kaar et al.
NEUROPHARMACOLOGY (2020)
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome
Enza Lacivita et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
(S)-5-(2′-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder
Jessica L. Armstrong et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
Devahuti Chaliha et al.
DEVELOPMENTAL NEUROSCIENCE (2020)
A Synthetic Fluorescent Mitochondria- Targeted Sensor for Ratiometric Imaging of Calcium in Live Cells
Diana Pendin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Serotonin receptor oligomerization regulates cAMP-based signaling
Sonal Prasad et al.
JOURNAL OF CELL SCIENCE (2019)
Differential serotonin transporter (5-HTT) and 5-HT2 receptor density in limbic and neocortical areas of adults and children with autism spectrum disorders: implications for selective serotonin reuptake inhibitor efficacy
Cheryl Brandenburg et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Vortioxetine Reduces Marble Burying but Only Transiently Enhances Social Interaction Preference in Adult Male BTBR T+Itpr3tf/J Mice
Nasriya A. Witt et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder
Daniele Vigil et al.
NEUROPHARMACOLOGY (2019)
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects
Pawel Zajdel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Serotonin neuron abnormalities in the BTBR mouse model of autism
Yue-Ping Guo et al.
AUTISM RESEARCH (2017)
5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice
D. A. Amodeo et al.
GENES BRAIN AND BEHAVIOR (2017)
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Enza Lacivita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome
Daniela Valenti et al.
NEUROPHARMACOLOGY (2017)
How serotonin receptors regulate morphogenic signalling in neurons
Alexander Wirth et al.
PROGRESS IN NEUROBIOLOGY (2017)
Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder
Marc Cantillon et al.
SCHIZOPHRENIA RESEARCH (2017)
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2016)
M100907 attenuates elevated grooming behavior in the BTBR mouse
Dionisio A. Amodeo et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics
Agnieszka A. Kaczor et al.
CHEMMEDCHEM (2016)
Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study
Enza Lacivita et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial
Diane C. Chugani et al.
JOURNAL OF PEDIATRICS (2016)
The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment
N. M. W. J. de Bruin et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
THE SEROTONIN SYSTEM IN AUTISM SPECTRUM DISORDER: FROM BIOMARKER TO ANIMAL MODELS
C. L. Muller et al.
NEUROSCIENCE (2016)
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models
Clinton E. Canal et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome
Bianca De Filippis et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Synthesis and Photooxygenation of Linear and Angular Furocoumarin Derivatives as a Hydroxyl Radical Source: Psoralen, Pseudopsoralen, Isopseudopsoralen, and Allopsoralen
Sameh Ramadan Elgogary et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2015)
Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor
Enza Lacivita et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands
Loredana Salerno et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Bianca De Filippis et al.
NEUROPSYCHOPHARMACOLOGY (2014)
5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model
Chao-Chuan Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics
Yin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior
Karsten Kinast et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
Lara Costa et al.
BIOLOGICAL PSYCHIATRY (2012)
Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin7 (5-HT7) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo
Enza Lacivita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and pharmacological activity of analogs of the endogenous neuropeptide cycloprolylglycine
K. N. Kolyasnikova et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2012)
Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T plus tf/J mouse social behavior
Georgianna G. Gould et al.
JOURNAL OF NEUROCHEMISTRY (2011)
LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2010)
Quantitative Measurement of cAMP Concentration Using an Exchange Protein Directly Activated by a cAMP-Based FRET-Sensor
Petrus S. Salonikidis et al.
BIOPHYSICAL JOURNAL (2008)
Applications of high throughput microsomal stability assay in drug discovery
Li Di et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Structure -: Activity relationship study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents.: 2
Marcello Leopoldo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C]2-(4-(4-(2-methoxyphenyl) piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3, 5(2H,4H)dione in nonhuman primates
J. S. Dileep Kumar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl) cyclohexane derivatives;: new, potent 5-HT1A receptor agents with anxiolytic-like activity
AJ Bojarski et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin-yl]butyl}-4-methy1-2H-[1,2,4]triazine-3,5-dione:: A novel 5-HT1A receptor agonist positron emission tomography ligand
JSD Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Pharmacophore models for metabotropic 5-HT receptor ligands
Andrzej J. Bojarski
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Synthesis and structure-activity relationships of a new model of arylpiperazines.: 8.: Computational simulation of ligand-receptor interaction of 5-HT1AR agonists with selectivity over α1-adrenoceptors
ML López-Rodríguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Identification of agonists and antagonists of the human melanocortin-4 receptor from piperazinebenzylamines
JA Tran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor
MR Guscott et al.
NEUROPHARMACOLOGY (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Serotonin and brain development: Role in human developmental diseases
PM Whitaker-Azmitia
BRAIN RESEARCH BULLETIN (2001)
Share Paper
